Actively Recruiting
Austrian Left Atrial Appendage Closure Registry
Led by Medical University of Graz · Updated on 2024-11-21
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on patients with atrial fibrillation who have undergone left atrial appendage closure (LAAC) in Austria. It aims to document all LAAC procedures performed in the country, particularly for patients with an indication for oral anticoagulation who have contraindications to such treatment. The study is observational and collects real-world data about this procedure. The study involves patients who received the LAAC device procedure, which is designed to close the left atrial appendage, a treatment option for stroke prevention in atrial fibrillation patients who cannot take oral anticoagulants. There are no additional treatment groups or interventions beyond documenting the LAAC procedures. Participants' involvement includes monitoring and recording outcomes such as the success of the LAAC procedure within 30 days, procedure-related adverse events during the same period, and long-term events like death, stroke, or bleeding over five years. The study observes participants over several years to gather safety and outcome data related to the LAAC procedure.
CONDITIONS
Brief Title
Austrian Left Atrial Appendage Closure Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who received left atrial appendage closure in Austria
You will not qualify if you...
- Absence of informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 30 days
Participants undergo left atrial appendage closure as part of routine care and are observed for procedure success and related events.
1 procedure visit and approximately 1 follow-up visit within 30 days
Duration - 5 years
Participants are monitored for death, stroke, or bleeding for up to 5 years after the procedure.
Regular follow-up visits as per clinical care
Trial Site Locations
Total: 1 location
1
Medical University of Graz
Graz, Austria, 8036
Actively Recruiting
Research Team
D
Daniel Scherr, Assoc.Prof. PD Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here